VIVO BIO TECH LTD. SHARE PRICE [LIVE]

  
NSE: VIVOBIOT
N/A
BSE: 511509
29.30
To view real time prices Login to your account
OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality

Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Not Applicable
Sector
-10.34%
Sensex
4.86%
IndustryPharma
MARKET CAP (Micro Cap Stock)Rs Cr
PE (TTM) 0.00
DIVIDEND YIELD 0.00%
PE Ratio39.06
Price to Book Value0.88
EV to EBIT13.03
EV to EBITDA6.34
EV to Capital Employed0.95
EV to Sales2.04
PEG Ratio0.00
Dividend YieldNA
ROCE (Latest)7.27%
ROE (Latest)2.26%
NameDec 22Sep 22
Promoters (Change:0.00) 42.16%42.16%
FIIs (Change:0.00) 0%0%
Mutual Funds (Change:0.00) 0%0%
Insurance Companies (Change:0.00) 0%0%
Other DIIs (Change:0.00) 0%0%
Non Institution (Change:-0.00) 57.84%57.84%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in VIVO BIO TECH LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

VIVOBIOT News

Frequently Asked Questions

What is the Share price of VIVO BIO TECH LTD. (VIVOBIOT)?

VIVO BIO TECH LTD. (VIVOBIOT) share price as of February 8, 2023, on BSE is Rs 29.30 (BSE).

Can I buy VIVO BIO TECH LTD. (VIVOBIOT) shares?

Yes, You can buy VIVO BIO TECH LTD. (VIVOBIOT) shares by opening a Demat account with Angel One.

How do I buy VIVO BIO TECH LTD. (VIVOBIOT) from Angel One?

VIVO BIO TECH LTD. (VIVOBIOT) share can be brought through the following modes:
  1. Direct investment: You can buy VIVO BIO TECH LTD. (VIVOBIOT) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to VIVO BIO TECH LTD. (VIVOBIOT) shares.

In which sector do VIVO BIO TECH LTD. (VIVOBIOT) belong?

VIVO BIO TECH LTD. (VIVOBIOT) belongs to Pharma.

About VIVOBIOT

Today's live share price for VIVO BIO TECH LTD. is NSE: N/A, BSE: ₹ 29.30 with a current market capitalization of .

Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients, we distinguish your development plan is as superlative as the products you bring to our testing facilities. The Biologic Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins. In-vitro Services offers solutions for pharmacologic, toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are specialty services by our scientists. The In-vivo Services group at Vivo Bio Tech provides both non-regulatory and regulatory IND enabling preclinical development services. We are capable of screening & evaluating molecules for various pharmacological & therapeutic properties. Specifically for oncology, our scientists can provide design & development of xenograft models for evaluation of anti-cancer agents. Further, our scientists can customize in-vivo DMPK studies to help profile your drug candidate in both rodent and non-rodent animal models. Vivo Bio has partnered with Taconic for sourcing foundation and expansion colonies of the animal models and have started in-house breeding of Specific Pathogen Free rodents.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers